Health·Updated hourly·1,983 stories
Health News Summary Today — Page 25
Medical breakthroughs, public health and scientific discoveries — quick news summary
NASA Calls ISS Crew Back After Roscosmos Pauses Repairs
NASA ordered the four Crew‑12 astronauts to board the docked Crew Dragon spacecraft and don spacesuits after an air leak in the Zvezda module worsened, but later announced the crew could resume normal
Marty Makary’s FDA Voucher Program Faces Overhaul
RevMed’s experimental pancreatic cancer drug daraxonrasib is being offered via an expanded access program, though patients still face hurdles obtaining it. Meanwhile, the FDA’s voucher program, launch
FDA Reviews Drug Program, Launches Mifepristone Study
The FDA held a listening session on its fast‑track drug review program, hearing from 17 stakeholders and receiving calls to pause the scheme and return to standard procedures. At the same time, the ag
Feyi-Waboso in race to face Boks after facial surgery
England winger Immanuel Feyi‑Waboso had facial surgery after a jaw injury in Exeter’s win over Leicester, ruling him out of the club’s final Premiership match against Saracens. The game, a playoff‑dec
Collatz Conjecture Stumps Math for 90 Years
The Collatz conjecture, a deceptively simple number rule proposed by Lothar Collatz in the 1930s, has stumped mathematicians for nearly a century, with the strongest progress coming from Terence Tao i
US Doctor’s Child Injured by Phenytoin in Scotland
An American pediatric emergency physician recounts how her 11‑month‑old daughter, Leela, suffered a severe extravasation injury after receiving phenytoin for a prolonged febrile seizure in a Scottish
S&P will not change the rules to allow SpaceX into its benchmark index early - Axios
S&P Global has reaffirmed its existing eligibility rules for the S&P 500 index, ruling out any early inclusion for SpaceX. The decision, reported by Axios, Bloomberg, Reuters and the Wall Street Journ
FDA Listens to 17 Critics on Makary’s Voucher Program
During a White Oak Campus listening session, the FDA heard from 17 speakers—including patient groups, drug firms, and academics—who largely urged a pause to the Commissioner’s National Priority Vouche
RevMed's Daraxonrasib Gets Standing Ovation at ASCO
The STAT podcast “The Readout LOUD” highlighted the enthusiastic reception of Revolution Medicines’ pancreatic cancer drug daraxonrasib at the ASCO meeting, featuring patient Leanna Stokes’ personal s
Otsuka's Voyxact Slows Kidney Decline to 3 Points/Year
Otsuka’s Phase 3 trial of its drug Voyxact in patients with IgA nephropathy showed an annualized eGFR decline of 3 points per year, versus 7.6 points for placebo. Although the drug slowed kidney funct
Zoetis, Elanco Stocks Surge After Texas Screwworm Case
A New World screwworm parasite was confirmed in Texas livestock, prompting a market rally for animal‑health firms. Zoetis shares rose nearly 4% and Elanco Animal Health up 2%, while Zoetis options vol
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
The U.S. Supreme Court issued a unanimous decision that Hikma Pharmaceuticals does not infringe Amarin's patents, overturning a lower‑court ruling that had favored Amarin. The ruling strengthens gener
Daraxonrasib doubles pancreatic cancer survival
Pancreatic cancer patient Amy Johnston, awaiting trial results, may turn to the experimental drug daraxonrasib if her current treatment fails. Daraxonrasib, developed by Revolution Medicines, nearly d
STAT+: RFK Jr.’s second year: Vacancies, not vaccines
Robert F. Kennedy Jr., America’s health secretary, has spent the first half of his tenure traveling across the country. He visited a regenerative farm in Ohio, met Wisconsin dairy farmers, and observe
A study of 8,300 older adults revealed a surprising salt habit
A study of 8,300 Brazilians aged 60 and older, published in Frontiers in Public Health, found that 12.7% of men and 9.4% of women regularly add extra salt at the table. Women’s salt‑adding habit was l
Jakob Uszkoreit Launches Inceptive Nucleics for RNA AI
Jakob Uszkoreit, co‑creator of the transformer architecture behind ChatGPT, is now focusing on RNA therapeutics through his startup Inceptive Nucleics. The company is building biological foundation mo
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
A new drug, daraxonrasib, which targets the KRAS mutation driving over 90% of pancreatic tumors, has shown in a landmark trial to nearly double survival for patients with advanced disease and cut the
Three Vaccine Papers RFK Jr. Cited Retracted or Under Scrutiny
Three scientific papers used to justify sweeping changes to US vaccine policy under Robert F. Kennedy Jr. have been retracted, removed, or placed under investigation by their publishers over the past
Daraxonrasib Gets FDA Approval for Pancreas Cancer
Revolution Medicines’ drug daraxonrasib has received a certain FDA approval for metastatic pancreatic cancer patients whose tumors progressed after chemotherapy, positioning it as the new second‑line
First Non-Repeating Biological Clock Found in Worms
Cold Spring Harbor Laboratory researchers have identified a two-protein feedback circuit — MYRF-1 and LIN-42 — that acts as the master developmental clock in C. elegans, coordinating precisely timed b
Get the Health newsletter
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.